Zobrazeno 1 - 10
of 19
pro vyhledávání: '"SHENGNING ZHANG"'
Autor:
Yuanyi Mang, MD, Yang Gao, MD, Yan Yang, MD, Mei Dong, MD, Qian Yang, MD, Hong Li, MD, Jianghua Ran, MD, Li Li, MD, Jun Ma, MD, Guoyu Chen, MD, Bin Yang, MD, Ying Xie, MD, Yunsong Wu, MD, Yingpeng Zhao, MD, Shengning Zhang, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 4, p e1598 (2024)
Externí odkaz:
https://doaj.org/article/0e66150ef21945928469c736fa0225b8
Autor:
Zongqiang Hu, Gang Chen, Yingpeng Zhao, Hongqiang Gao, Laibang Li, Yanfeng Yin, Jie Jiang, Li Wang, Yuanyi Mang, Yang Gao, Shengning Zhang, Jianghua Ran, Li Li
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-21 (2023)
Abstract Background Circular RNAs (circRNAs) can be encapsulated into exosomes to participate in intercellular communication, affecting the malignant progression of a variety of tumors. Dysfunction of CD8 + T cells is the main factor in immune escape
Externí odkaz:
https://doaj.org/article/ba4d4b1f61894f11b5060aee77b43e29
Publikováno v:
Cell Transplantation, Vol 31 (2022)
Human umbilical cord mesenchymal stem cell (HUMSC)-exosome gel played a significant role in promoting thin endometrial receptivity and improving the pregnancy rate by inhibiting endometrial fibrosis and accelerating subendometrial microangiogenesis.
Externí odkaz:
https://doaj.org/article/0b328eb862024576b92bb06e04388653
Publikováno v:
Indian Journal of Pharmaceutical Sciences. Mar/Apr2024, Vol. 86 Issue 2, p606-619. 14p.
Publikováno v:
Nonlinear Dynamics. 110:3737-3750
Publikováno v:
Environmental Toxicology.
Autor:
Shengning Zhang, Yaokun Li
Publikováno v:
SOLA. 18:254-258
Autor:
Wang Li, Ruichao Wu, Shengning Zhang, Yingpeng Zhao, Laibang Li, Zongqiang Hu, Qiuming Su, Yuanyi Mang, Xibing Zhang, Yun Dong, Kepu Zheng, Jianghua Ran, Li Li
Publikováno v:
Clinical and Translational Oncology.
Autor:
Shengning Zhang, Yuanyi Mang, Li Li, Jianghua Ran, Yingpeng Zhao, Laibang Li, Yang Gao, Wang Li, Guoyu Chen, Jun Ma
Publikováno v:
Journal of Gastrointestinal Oncology. 12:3033-3049
Background Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, which the 5-year survival rate has not substantially improved in the past few decades. We aimed to explore the potential role of peroxisome proliferator act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d005e71cfdf80f818c9ff9af5e0e29bb
https://doi.org/10.21203/rs.3.rs-1943906/v1
https://doi.org/10.21203/rs.3.rs-1943906/v1